ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 44580 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 44580; 2) Community: the network communities that were significantly associated with the response to NSC 44580; 3) Molecule: the relationships between components within communities and NSC 44580; 4) MDR: the compounds that were significantly associated with the NSC 44580.

NSC Compound Enrichment Correlation
NSC 693248 Null 0.0352028253287042 0.07883683
NSC 693322 Hydrazinecarbothioamide, 2,2'-(1,2-ethanediylidene)bis[N,N-dimethyl- 0.0352028253287042 0.16059618
NSC 703784 L-Lysinamide, N-[4-(1,3-benzothiazol-2-yl)phenyl-2-chlorophenyl]-,dihydrochloride 0.0352028253287042 -0.086620365
NSC 709974 Null 0.0352028253287042 0.48033977
NSC 718564 Null 0.0352028253287042 0.30448782
NSC 718630 Null 0.0352028253287042 0.28023271
NSC 718781 Erlotinib hydrochloride 0.0352028253287042 -0.068375204
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0352028253287042 0.0083877754
NSC 726089 11-(4-dimethylaminobenzyliden)-8-methoxy-5-methyl-11H-indolo [1,2-b]indazolium trifluoromethanesulfonate 0.0352028253287042 0.2120581
NSC 726217 Combretastatin A4-analogue 0.0352028253287042 0.28843441
Total:91  Current:63    [First] [Prev] [Next] [Last]